Algo version: 0.98b
Laboratory Corporation of is listed at the NYSE Exchange
Laboratory Corporation of [LH]
NYSE Sector: Healthcare Industry:Medical - Diagnostics & Research

Is Laboratory Corporation of stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Laboratory Corporation of pays dividends. Last time was Friday 13th of September 2024 where the investors holding the stock on Thursday 29th of August 2024 were paid $0.72 per share. Over the last 25 times between 1990 and 2024, Laboratory Corporation of has paid $8.96 with an average of $0.36 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Laboratory Corporation of 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $148.17, you would have made a profit of $75.74 per share or 51.12%

Yes, the average daily trading liquidity for Laboratory Corporation of is $569 006 thousand. You should therefore be able to get in and out of your positions relatively fast.

Laboratory Corporation of has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.22, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 3.52%, which is challenging.

We have calculated the inflation risk for Laboratory Corporation of to be low [0.5 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.